1. Insanitary conditions at compounding facilities Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2020 Subject(s): Drug CompoundingDrug Industry -- standardsFacility Regulation and ControlUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
2. Policy for testing of alcohol (ethanol) and isopropyl alcohol for methanol, including during the public health emergency (COVID-19) Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021 Subject(s): 2-PropanolDrug CompoundingEthanolMethanolCOVID-19United StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
3. S11 nonclinical safety testing in support of development of pediatric pharmaceuticals Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2021 Subject(s): Drug CompoundingDrug IndustryPediatricsPharmaceutical PreparationsQuality ControlUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration